OphtiMed Rx LTD is an ophthalmic drug development company, led by a team of physicians, scientists, and molecular biology experts.
The company is developing a novel molecular therapy for dry Age-related Macular Degeneration (AMD), a common eye disease leading to blindness. This treatment protects retinal cells from senescence (cellular aging) and can halt progression of dry AMD.
Our cutting-edge therapy will prevent the loss of vision and independence and bring enormous benefit to patients.


Health Care

Life Sciences

Medical Devices

Therapeutics

OphtiMed Rx

OphtiMed Rx's headquarters in Katzrin, Israel

Description

People (1)

Jobs (0)

Other offices